Skip to content
10-Q

Quarterly Report

ACUTUS MEDICAL, INC.

0001628280-24-036236

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 6, 2024 29.78M sh
Shares Diluted Q2 2024 · Jun 30, 2024 29.72M sh
Shares Diluted Q2 2024 · Jun 30, 2024 29.73M sh
Shares Diluted Q2 2024 · Jun 30, 2023 29.04M sh
Shares Diluted Q2 2024 · Jun 30, 2023 28.9M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $0
Stock Repurchased restated Q2 2024 · Jun 30, 2023 $23K
Capex Q2 2024 · Jun 30, 2024 $143K
Capex restated Q2 2024 · Jun 30, 2023 $777K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$23.9M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$31.1M
Long Term Debt Q2 2024 · Jun 30, 2024 $25.13M
Long Term Debt Q2 2024 · Dec 31, 2023 $32.65M
Short Term Debt Q2 2024 · Jun 30, 2024 $7.06M
Short Term Debt Q2 2024 · Dec 31, 2023 $1.86M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $13.33M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $19.17M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$4.81M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$4.02M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$879K
Stockholders Equity Q2 2024 · Jun 30, 2023 $43.74M
Stockholders Equity Q2 2024 · Mar 31, 2023 $60.47M
Stockholders Equity Q2 2024 · Dec 31, 2022 $75.02M
Current Liabilities Q2 2024 · Jun 30, 2024 $12.38M
Current Liabilities Q2 2024 · Dec 31, 2023 $18.94M
Total Liabilities Q2 2024 · Jun 30, 2024 $40.28M
Total Liabilities Q2 2024 · Dec 31, 2023 $54.84M
Current Assets Q2 2024 · Jun 30, 2024 $28.46M
Current Assets Q2 2024 · Dec 31, 2023 $46.25M
Total Assets Q2 2024 · Jun 30, 2024 $35.47M
Total Assets Q2 2024 · Dec 31, 2023 $53.96M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.03
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.09
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.63
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.20
Eps Basic Q2 2024 · Jun 30, 2024 −$0.03
Eps Basic Q2 2024 · Jun 30, 2024 −$0.09
Eps Basic Q2 2024 · Jun 30, 2023 −$0.63
Eps Basic Q2 2024 · Jun 30, 2023 −$1.20
Sga Expense Q2 2024 · Jun 30, 2024 $2.23M
Sga Expense Q2 2024 · Jun 30, 2024 $5.56M
Sga Expense restated Q2 2024 · Jun 30, 2023 $3.28M
Sga Expense restated Q2 2024 · Jun 30, 2023 $7.75M
Rd Expense Q2 2024 · Jun 30, 2024 $0
Rd Expense Q2 2024 · Jun 30, 2024 $0
Rd Expense restated Q2 2024 · Jun 30, 2023 $917K
Rd Expense restated Q2 2024 · Jun 30, 2023 $1.86M
Net Income Q2 2024 · Jun 30, 2024 −$914K
Net Income Q2 2024 · Jun 30, 2024 −$2.53M
Net Income Q2 2024 · Jun 30, 2023 −$18.35M
Net Income Q2 2024 · Jun 30, 2023 −$34.66M
Operating Income Q2 2024 · Jun 30, 2024 $301K
Operating Income Q2 2024 · Jun 30, 2024 −$274K
Operating Income restated Q2 2024 · Jun 30, 2023 −$3.06M
Operating Income restated Q2 2024 · Jun 30, 2023 −$8.33M
Gross Profit Q2 2024 · Jun 30, 2024 −$343K
Gross Profit Q2 2024 · Jun 30, 2024 −$373K
Gross Profit restated Q2 2024 · Jun 30, 2023 −$1.01M
Gross Profit restated Q2 2024 · Jun 30, 2023 −$1.88M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $4.47M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $8.13M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $2.53M
Cost Of Revenue restated Q2 2024 · Jun 30, 2023 $4.64M
Revenue Q2 2024 · Jun 30, 2024 $4.13M
Revenue Q2 2024 · Jun 30, 2024 $7.75M
Revenue restated Q2 2024 · Jun 30, 2023 $1.52M
Revenue restated Q2 2024 · Jun 30, 2023 $2.76M